Enrich Layer logo svg
Bristol Myers Squibb logo

Bristol Myers Squibb

Last updated: . For recent data, use our API.

Overview

(NYSE: BMY · $61.48 ▼ 2.4%) At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients.

Bristol Myers Squibb is a global biopharmaceutical company. In oncology, the company builds on its heritage in the treatment of solid tumors and works on complex scientific problems for cancer patients. Its hematology work targets diseases with high unmet need. Its immunology programs address unmet needs in dermatology, gastroenterology, pulmonology and rheumatology. The company's cardiovascular research draws on a 70-year history of developing medicines in the field. Its research also extends to neuroscience, where it develops disease-modifying and symptomatic therapies for people living with neurological and psychiatric diseases.

Through the Bristol Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions. Our mission is to give new hope to help patients prevail over serious disease – it drives everything we do. Review our Social Media Community Guidelines at: https://www.bms.com/social-media-community-guidelines.html

Private funding before listing

Disclosed funding: $42.5M across 5 rounds. Latest: Grant, 11 Aug 2026.

3 rounds have an undisclosed amount, not included in the total.

DateTypeAmount
11 Aug 2026GrantNot disclosed
More funding rounds via API
Get company data via API

Get company records through the Enrich Layer API. These pages show previews only.

Latest videos from Bristol Myers Squibb on YouTube

  • Bristol Myers Squibb | Won't Lose Voices: Chris
  • Bristol Myers Squibb | Won't Lose Voices: Lexi
  • Beyond the Tumor: From Biology to Behavior – Part 1
  • Beyond the Tumor: From Evidence to Action – Part 2
View channel

Recent posts from the Bristol Myers Squibb blog

Bristol Myers Squibb FAQ

As of 2026-10-19, Bristol Myers Squibb has 33,139 employees, based on the Enrich Layer count of person profiles that list Bristol Myers Squibb as their current employer. Its listed company size band is 10,001+.
As of 2026-10-19, Bristol Myers Squibb is headquartered in Lawrence Township, NJ, US.
As of 2026-10-19, Bristol Myers Squibb is classified in the Pharmaceutical Manufacturing industry.
At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome.
As of 2026-10-19, Bristol Myers Squibb's official website is http://www.bms.com/.
As of 2026-10-19, Bristol Myers Squibb is a public company.